1 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA. kornelia_polyak@dfci.harvard.edu
Translating functional genomics screens into therapeutic interventions for treating breast cancer has presented challenges. Identifying synthetic lethal interactions in cancer cells using these screens may hold promise.